Prostatic Neoplasms
1 competing product in clinical development for Prostatic Neoplasms.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Abemaciclib + Darolutamide + LHRH agonist/antagonist | Eli Lilly | Phase 1 | Completed | 33 |